DAVA
Endava plc
There isn't enough reported data to score DAVA yet.
NVDA
NVIDIA Corporation
NVDA's fundamentals are strong and it looks cheap: trading at 21x earnings, about a third of its usual 65x. Analysts expect strong earnings growth.
DAVA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Under pressure |
DAVA's revenue is currently stable, but its profitability, cash flow and balance sheet are under pressure.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
DAVA PE Valuation
DAVA has no meaningful PE right now: it lost money over the past year.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
DAVA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect DAVA's earnings to grow and its profitability to improve, with its revenue holding steady.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
DAVA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q1 2026 | -$10.60 | -2818% |
| Q4 2025 | -$0.11 | -192% |
| Q3 2025 | $0.21 | +31% |
| Q2 2025 | $0.46 | +21% |
| Q1 2025 | $0.39 | -59% |
| Q4 2024 | $0.12 | -92% |
| Q3 2024 | $0.16 | -91% |
| Q2 2024 | $0.38 | -82% |
DAVA has swung to a loss: it lost $10.60 per share over the past year, after a profit the year before.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over DAVA on earnings quality, reporting a profit while its opponent remains loss making.
DAVA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $242.7M | -6.4% |
| Q4 2025 | $241.7M | -7.1% |
| Q3 2025 | $237M | -8.6% |
| Q2 2025 | $248.5M | -3.9% |
| Q1 2025 | $259.2M | +12% |
| Q4 2024 | $260.2M | +6.6% |
| Q3 2024 | $259.5M | +3.5% |
| Q2 2024 | $258.6M | +2.4% |
DAVA's revenue is shrinking: $243M last quarter, down 6.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2026 | -3.4% | -12 points |
| Q4 2025 | -2.3% | -3.2 points |
| Q3 2025 | -1.6% | -4 points |
| Q2 2025 | 4.7% | +4 points |
| Q1 2025 | 8.4% | +9.5 points |
| Q4 2024 | 0.9% | -1.7 points |
| Q3 2024 | 2.4% | -6.2 points |
| Q2 2024 | 0.6% | -11 points |
DAVA's operating margin was −3.4% last quarter, down 12 points from the same quarter a year ago, near the bottom of its range since 2019.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over DAVA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over DAVA on profitability, with a higher operating margin.
DAVA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$7.4M | -132% |
| Q4 2025 | $24.2M | -42% |
| Q3 2025 | $12.2M | +183% |
| Q2 2025 | -$5.4M | -$2.7M |
| Q1 2025 | $23M | +1044% |
| Q4 2024 | $42.1M | -6% |
| Q3 2024 | $4.3M | -79% |
| Q2 2024 | -$2.7M | -106% |
DAVA usually generates cash, though not every quarter: the latest was −$7M, but it generated $24M over the past year.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over DAVA on cash flow, with more consistent year-over-year improvement.
DAVA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -644K shares |
| 1 year | -12% | -7.2M shares |
| 3 years | -10% | -6M shares |
| 5 years | -8.7% | -5M shares |
| Available history | -5.4% | -3M shares |
DAVA has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2026 | $3.4M |
| Q4 2025 | $2.4M |
| Q3 2025 | $30.5M |
| Q2 2025 | $62.5M |
| Q1 2025 | $23.7M |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
DAVA spent $99M buying back its own shares over the past year, about four times what it spent the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
DAVA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | 3.5x | Elevated |
| Q3 2025 | 2.9x | Moderate |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 1.4x | Healthy |
| Q4 2024 | 1.8x | Healthy |
| Q3 2024 | 2.0x | Moderate |
| Q2 2024 | 1.8x | Healthy |
| Q1 2024 | -1.5x | Net Cash |
DAVA's net debt is about 3.5 years of its operating earnings (EBITDA), up from 1.8 years a year ago.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
DAVA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.2 | Oversold |
| Stochastic | 5.2 | Oversold |
DAVA's weekly RSI is 29 (oversold) and its Stochastic is 5 (oversold).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
DAVA PE vs Technology Sector
| Metric | DAVA | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
DAVA has no meaningful PE right now: it lost money over the past year.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
DAVA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.84 | 17% below |
| 20 week MA | $2.51 | 39% below |
| 50 week MA | $3.94 | 61% below |
| 100 week MA | $10.7 | 86% below |
| 200 week MA | $29.8 | 95% below |
DAVA is in a downtrend: it's below all five of its weekly moving averages, and 95% below its 200-week average.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has the edge over DAVA on trend strength, trading above more of its moving averages.
DAVA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48.7 | $77.3 | +59% |
| 2021 | $77.3 | $163.1 | +111% |
| 2022 | $163.1 | $74.8 | -54% |
| 2023 | $74.8 | $77.9 | +4.1% |
| 2024 | $77.9 | $30.5 | -61% |
| 2025 | $30.5 | $6.62 | -78% |
| 2026 YTD | $6.62 | $1.52 | -77% |
DAVA's yearly returns have swung widely, from +111% in 2021 to −78% in 2025. It's down 77% so far in 2026.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over DAVA on returns for 2026, with the stronger performance.